Hikma Starts Added-Value Push With Heparin Syringes

 
• By Aidan Fry

Heparin marks the start of Hikma’s pre-filled syringe portfolio in the US as the company looks to add value and differentiation to its injectables portfolio and pipeline, commercial and business development head Dan Motto told Generics Bulletin.

Syringe
Hikma is looking to add value to its US injectables portfolio by moving into pre-filled syringes • Source: Shutterstock

More from Products

More from Generics Bulletin